$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles 원문보기

Drug design, development and therapy, v.13, 2019년, pp.327 - 343  

Van Giau, Vo (Department of Bionano Technology, Gachon Bionano Research Institute, Gachon University, Seongnam-si, Gyeonggi-do, South Korea, johnhulme21@gmail.com) ,  An, Seong Soo A (seong.an@gmail.com) ,  Hulme, John (Department of Bionano Technology, Gachon Bionano Research Institute, Gachon University, Seongnam-si, Gyeonggi-do, South Korea, johnhulme21@gmail.com)

Abstract ▼ AI-Helper 아이콘AI-Helper

The worldwide misuse of antibiotics and the subsequent rise of multidrug-resistant pathogenic bacteria have prompted a paradigm shift in the established view of antibiotic and bacterial–human relations. The clinical failures of conventional antibiotic therapies are associated with lengthy det...

주제어

#antibiotics   #resistance   #polymer   #chitosan   #gold   #recombinant   #targeted   #pathogen  

참고문헌 (185)

  1. 1 D’Costa VM King CE Kalan L Antibiotic resistance is ancient Nature 2011 477 7365 457 461 21881561 

    상세보기

  2. 2 Martinez JL General principles of antibiotic resistance in bacteria Drug Discov Today Technol 2014 11 33 39 24847651 

  3. 3 McFall-Ngai M Hadfield MG Bosch TC Animals in a bacterial world, a new imperative for the life sciences Proc Natl Acad Sci U S A 2013 110 9 3229 3236 23391737 

    상세보기

  4. 4 van Schaik W The human gut resistome Philos Trans R Soc Lond B Biol Sci 2015 370 1670 20140087 25918444 

  5. 5 Davies J Davies D Origins and evolution of antibiotic resistance Microbiol Mol Biol Rev 2010 74 3 417 433 20805405 

    상세보기

  6. 6 Potgieter M Bester J Kell DB Pretorius E The dormant blood microbiome in chronic, inflammatory diseases FEMS Microbiol Rev 2015 39 4 567 591 25940667 

    상세보기

  7. 7 Najar MS Saldanha CL Banday KA Approach to urinary tract infections Indian J Nephrol 2009 19 4 129 139 20535247 

  8. 8 Kell D Potgieter M Pretorius E Individuality, phenotypic differentiation, dormancy and “persistence” in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology F1000Res 2015 4 179 26629334 

    상세보기

  9. 9 Pinto D São-José C Santos MA Chambel L Characterization of two resuscitation promoting factors of Listeria monocytogenes Microbiology 2013 159 Pt 7 1390 1401 23676438 

  10. 10 Lungu B Ricke SC Johnson MG Growth, survival, proliferation and pathogenesis of Listeria monocytogenes under low oxygen or anaerobic conditions: a review Anaerobe 2009 15 1–2 7 17 18926916 

  11. 11 Audoly G Fenollar F Lagier JC Lepidi H Raoult D Deglycosylation of Tropheryma whipplei biofilm and discrepancies between diagnostic results during Whipple’s disease progression Sci Rep 2016 6 1 23883 27025850 

  12. 12 Kim ES Kim HB Kim G Korea INfectious Diseases (KIND) study group Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea PLoS One 2014 9 12 e114127 25485895 

    상세보기

  13. 13 Buchan BW Ledeboer NA Emerging technologies for the clinical microbiology laboratory Clin Microbiol Rev 2014 27 4 783 822 25278575 

    상세보기

  14. 14 Cohen J Vincent JL Adhikari NK Sepsis: a roadmap for future research Lancet Infect Dis 2015 15 5 581 614 25932591 

    상세보기

  15. 15 Lafleur LK Bishop JD Heiniger EK A rapid, instrument-free, sample-to-result nucleic acid amplification test Lab Chip 2016 16 19 3777 3787 27549897 

    상세보기

  16. 16 Doyle MP Loneragan GH Scott HM Singer RS Antimicrobial resistance: challenges and perspectives Compr Rev Food Sci Food Saf 2013 12 2 234 248 

  17. 17 Winnicka K Wroblewska M Wieczorek P Sacha PT Tryniszewska EA The effect of PAMAM dendrimers on the antibacterial activity of antibiotics with different water solubility Molecules 2013 18 7 8607 8617 23881050 

    상세보기

  18. 18 Gao W Thamphiwatana S Angsantikul P Zhang L Nanoparticle approaches against bacterial infections Wiley Interdiscip Rev Nanomed Nanobiotechnol 2014 6 6 532 547 25044325 

    상세보기

  19. 19 Hulme J Recent advances in the detection of methicillin resistant Staphylococcus aureus (MRSA) BioChip J 2017 11 2 89 100 

    상세보기

  20. 20 Xiong MH Bao Y Yang XZ Zhu YH Wang J Delivery of antibiotics with polymeric particles Adv Drug Deliv Rev 2014 78 63 76 24548540 

    상세보기

  21. 21 Couvreur P Nanoparticles in drug delivery: past, present and future Adv Drug Deliv Rev 2013 65 1 21 23 22580334 

    상세보기

  22. 22 Abed N Couvreur P Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections Int J Antimicrob Agents 2014 43 6 485 496 24721232 

  23. 23 Wang L Hu C Shao L The antimicrobial activity of nanoparticles: present situation and prospects for the future Int J Nanomedicine 2017 12 1227 1249 28243086 

  24. 24 Pelgrift RY Friedman AJ Nanotechnology as a therapeutic tool to combat microbial resistance Adv Drug Deliv Rev 2013 65 13–14 1803 1815 23892192 

  25. 25 Rai M Ingle AP Pandit R Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance Int J Pharm 2017 532 1 139 148 28870767 

    상세보기

  26. 26 Torres-Sangiao E Holban A Gestal MC Advanced nanobiomaterials: vaccines, diagnosis and treatment of infectious diseases Molecules 2016 21 7 867 

    상세보기

  27. 27 Carabineiro SAC Applications of gold nanoparticles in nanomedicine: recent advances in vaccines Molecules 2017 22 5 E857 28531163 

  28. 28 Rizvi SMD Hussain T Ahmed ABF Gold nanoparticles: a plausible tool to combat neurological bacterial infections in humans Biomed Pharmacother 2018 107 7 18 30075371 

    상세보기

  29. 29 Assolini JP Concato VM Gonçalves MD Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications Parasitol Res 2017 116 6 1603 1615 28477099 

    상세보기

  30. 30 Hemeg HA Nanomaterials for alternative antibacterial therapy Int J Nanomedicine 2017 12 8211 8225 29184409 

  31. 31 Baptista PV McCusker MP Carvalho A Nano-strategies to fight multidrug resistant bacteria – “A Battle of the Titans” Front Microbiol 2018 9 1441 30013539 

  32. 32 Yang K Han Q Chen B Antimicrobial hydrogels: promising materials for medical application Int J Nanomedicine 2018 13 2217 2263 29695904 

  33. 33 Gao W Chen Y Zhang Y Zhang Q Zhang L Nanoparticle-based local antimicrobial drug delivery Adv Drug Deliv Rev 2018 127 46 57 28939377 

    상세보기

  34. 34 Dos Santos Ramos MA Da Silva PB Spósito L Nanotechnology-based drug delivery systems for control of microbial biofilms: a review Int J Nanomedicine 2018 13 1179 1213 29520143 

  35. 35 Hibbitts A O’Leary C Emerging nanomedicine therapies to counter the rise of methicillin-resistant Staphylococcus aureus Materials (Basel) 2018 11 2 E321 29473883 

  36. 36 Khurana C Chudasama B Nanoantibiotics: strategic assets in the fight against drug-resistant superbugs Int J Nanomedicine 2018 13 3 6 29593387 

  37. 37 Liu W das J Mepham AH Nemr CR Sargent EH Kelley SO A fully-integrated and automated testing device for PCR-free viral nucleic acid detection in whole blood Lab Chip 2018 18 13 1928 1935 29881833 

    상세보기

  38. 38 Cheng D Yu M Fu F Dual recognition strategy for specific and sensitive detection of bacteria using aptamer-coated magnetic beads and antibiotic-capped gold nanoclusters Anal Chem 2016 88 1 820 825 26641108 

    상세보기

  39. 39 Sung YJ Suk HJ Sung HY Li T Poo H Kim MG Novel antibody/gold nanoparticle/magnetic nanoparticle nanocomposites for immunomagnetic separation and rapid colorimetric detection of Staphylococcus aureus in milk Biosens Bioelectron 2013 43 432 439 23370174 

    상세보기

  40. 40 Kumar N Kulkarni K Behera L Verma V Preparation and characterization of maghemite nanoparticles from mild steel for magnetically guided drug therapy J Mater Sci Mater Med 2017 28 8 116 28681216 

  41. 41 Kearns H Goodacre R Jamieson LE Graham D Faulds K SERS detection of multiple antimicrobial-resistant pathogens using nanosensors Anal Chem 2017 89 23 12666 12673 28985467 

    상세보기

  42. 42 Cowger TA Yang Y Rink DE Protein-adsorbed magnetic-nanoparticle-mediated assay for rapid detection of bacterial antibiotic resistance Bioconjug Chem 2017 28 4 890 896 28192992 

    상세보기

  43. 43 Wei X Zhou W Sanjay ST Multiplexed instrument-free bar-chart spinchip integrated with nanoparticle-mediated magnetic aptasensors for visual quantitative detection of multiple pathogens Anal Chem 2018 90 16 9888 9896 30028601 

    상세보기

  44. 44 Gupta AK Naregalkar RR Vaidya VD Gupta M Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications Nanomedicine (Lond) 2007 2 1 23 39 17716188 

  45. 45 Corchero JL Villaverde A Biomedical applications of distally controlled magnetic nanoparticles Trends Biotechnol 2009 27 8 468 476 19564057 

  46. 46 Chung HJ Castro CM Im H Lee H Weissleder R A magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria Nat Nanotechnol 2013 8 5 369 375 23644570 

    상세보기

  47. 47 Park KS Kim H Kim S Nanomagnetic system for rapid diagnosis of acute infection ACS Nano 2017 11 11 11425 11432 29121461 

    상세보기

  48. 48 Diekema DJ Beach ML Pfaller MA Jones RN SENTRY Participants Group Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America Clin Microbiol Infect 2001 7 3 152 157 11318814 

  49. 49 Bubeck Wardenburg J Williams WA Missiakas D Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins Proc Natl Acad Sci U S A 2006 103 37 13831 13836 16954184 

    상세보기

  50. 50 Kaim AH Wischer T O’Reilly T MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats Radiology 2002 225 3 808 814 12461265 

    상세보기

  51. 51 Liu J Bai R Li Y MRI detection of bacterial brain abscesses and monitoring of antibiotic treatment using bacCEST Magn Reson Med 2018 80 2 662 671 29577382 

    상세보기

  52. 52 Hoerr V Tuchscherr L Hüve J Bacteria tracking by in vivo magnetic resonance imaging BMC Biol 2013 11 1 63 23714179 

  53. 53 Moro L Turemis M Marini B Ippodrino R Giardi MT Better together: strategies based on magnetic particles and quantum dots for improved biosensing Biotechnol Adv 2017 35 1 51 63 27923765 

    상세보기

  54. 54 Veigas B Fernandes AR Baptista PV AuNPs for identification of molecular signatures of resistance Front Microbiol 2014 5 455 25221547 

    상세보기

  55. 55 Law JW Ab Mutalib NS Chan KG Lee LH Rapid methods for the detection of foodborne bacterial pathogens: principles, applications, advantages and limitations Front Microbiol 2014 5 770 25628612 

    상세보기

  56. 56 Kumar N Hu Y Singh S Mizaikoff B Emerging biosensor platforms for the assessment of water-borne pathogens Analyst 2018 143 2 359 373 29271425 

    상세보기

  57. 57 Mocan T Matea CT Pop T Development of nanoparticle-based optical sensors for pathogenic bacterial detection J Nanobiotechnology 2017 15 1 25 28359284 

  58. 58 Amendola V Pilot R Frasconi M Maragò OM Iatì MA Surface plasmon resonance in gold nanoparticles: a review J Phys Condens Matter 2017 29 20 203002 28426435 

  59. 59 Elghanian R Storhoff JJ Mucic RC Letsinger RL Mirkin CA Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles Science 1997 277 5329 1078 1081 9262471 

    상세보기

  60. 60 Storhoff JJ Marla SS Bao P Gold nanoparticle-based detection of genomic DNA targets on microarrays using a novel optical detection system Biosens Bioelectron 2004 19 8 875 883 15128107 

    상세보기

  61. 61 Chan WS Tang BS Boost MV Chow C Leung PH Detection of methicillin-resistant Staphylococcus aureus using a gold nanoparticle-based colourimetric polymerase chain reaction assay Biosens Bioelectron 2014 53 105 111 24125759 

    상세보기

  62. 62 Wu S-Y Hulme J An SSA Recent trends in the detection of pathogenic Escherichia coli O157:H7 BioChip J 2015 9 3 173 181 

    상세보기

  63. 63 Tsai TT Huang CY Chen CA Diagnosis of tuberculosis using colorimetric gold nanoparticles on a paper-based analytical device ACS Sens 2017 2 9 1345 1354 28901134 

  64. 64 Cheon SA Cho HH Kim J Lee J Kim HJ Park TJ Recent tuberculosis diagnosis toward the end TB strategy J Microbiol Methods 2016 123 51 61 26853124 

    상세보기

  65. 65 Tang L Li J Plasmon-based colorimetric nanosensors for ultrasensitive molecular diagnostics ACS Sens 2017 2 7 857 875 28750528 

  66. 66 Foubert A Beloglazova NV Rajkovic A Bioconjugation of quantum dots: review and impact on future application TrAC Trends Anal Chem 2016 83 31 48 

  67. 67 Goldman ER Clapp AR Anderson GP Multiplexed toxin analysis using four colors of quantum dot fluororeagents Anal Chem 2004 76 3 684 688 14750863 

    상세보기

  68. 68 Banerjee R Jaiswal A Recent advances in nanoparticle-based lateral flow immunoassay as a point-of-care diagnostic tool for infectious agents and diseases Analyst 2018 143 9 1970 1996 29645058 

    상세보기

  69. 69 Morales-Narváez E Naghdi T Zor E Merkoçi A Photoluminescent lateral-flow immunoassay revealed by graphene oxide: highly sensitive paper-based pathogen detection Anal Chem 2015 87 16 8573 8577 26205473 

    상세보기

  70. 70 Jin B Wang S Lin M Upconversion nanoparticles based FRET aptasensor for rapid and ultrasenstive bacteria detection Biosens Bio-electron 2017 90 525 533 

    상세보기

  71. 71 Date AA Hanes J Ensign LM Nanoparticles for oral delivery: design, evaluation and state-of-the-art J Control Release 2016 240 504 526 27292178 

    상세보기

  72. 72 Brooks BD Brooks AE Therapeutic strategies to combat antibiotic resistance Adv Drug Deliv Rev 2014 78 14 27 25450262 

    상세보기

  73. 73 Laverman P Dams ET Storm G Microscopic localization of PEG-liposomes in a rat model of focal infection J Control Release 2001 75 3 347 355 11489321 

    상세보기

  74. 74 Tran N Hocquet M Eon B Non-lamellar lyotropic liquid crystalline nanoparticles enhance the antibacterial effects of rifampicin against Staphylococcus aureus J Colloid Interface Sci 2018 519 107 118 29486430 

    상세보기

  75. 75 Kaleko M Bristol JA Hubert S Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection Anaerobe 2016 41 58 67 27262694 

    상세보기

  76. 76 Dickson RP Erb-Downward JR Huffnagle GB The role of the bacterial microbiome in lung disease Expert Rev Respir Med 2013 7 3 245 257 23734647 

  77. 77 Spicer CD Jumeaux C Gupta B Stevens MM Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications Chem Soc Rev 2018 47 10 3574 3620 29479622 

    상세보기

  78. 78 Chen H Li M Liu Z Design of antibacterial peptide-like conjugated molecule with broad spectrum antimicrobial ability Sci China Chem 2018 61 1 113 117 

  79. 79 Zhao X Pan F Xu H Molecular self-assembly and applications of designer peptide amphiphiles Chem Soc Rev 2010 39 9 3480 3498 20498896 

    상세보기

  80. 80 Mitra RN Shome A Paul P Das PK Antimicrobial activity, biocompatibility and hydrogelation ability of dipeptide-based amphiphiles Org Biomol Chem 2009 7 1 94 102 19081951 

    상세보기

  81. 81 Radovic-Moreno AF Lu TK Puscasu VA Yoon CJ Langer R Farokhzad OC Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics ACS Nano 2012 6 5 4279 4287 22471841 

    상세보기

  82. 82 Cao B Xiao F Xing D Hu X Polyprodrug antimicrobials: remarkable membrane damage and concurrent drug release to combat antibiotic resistance of methicillin-resistant Staphylococcus aureus Small 2018 14 41 e1802008 30118562 

  83. 83 Liu P Xu G Pranantyo D Xu LQ Neoh K-G Kang E-T pH-sensitive zwitterionic polymer as an antimicrobial agent with effective bacterial targeting ACS Biomater Sci Eng 2018 4 1 40 46 

    상세보기

  84. 84 Mankoci S Kaiser RL Sahai N Barton HA Joy A Bactericidal peptidomimetic polyurethanes with remarkable selectivity against Escherichia coli ACS Biomater Sci Eng 2017 3 10 2588 2597 

  85. 85 Jadhav M Kalhapure RS Rambharose S Novel lipids with three C18-fatty acid chains and an amino acid head group for pH-responsive and sustained antibiotic delivery Chem Phys Lipids 2018 212 12 25 29305156 

    상세보기

  86. 86 Chu L Gao H Cheng T A charge-adaptive nanosystem for prolonged and enhanced in vivo antibiotic delivery Chem Commun (Camb) 2016 52 37 6265 6268 27077219 

  87. 87 Gillies ER Fréchet JM pH-Responsive copolymer assemblies for controlled release of doxorubicin Bioconjug Chem 2005 16 2 361 368 15769090 

    상세보기

  88. 88 Kalhapure RS Sikwal DR Rambharose S Enhancing targeted antibiotic therapy via pH responsive solid lipid nanoparticles from an acid cleavable lipid Nanomedicine 2017 13 6 2067 2077 28434930 

  89. 89 Wang J Byrne JD Napier ME DeSimone JM More effective nano-medicines through particle design Small 2011 7 14 1919 1931 21695781 

    상세보기

  90. 90 Hejazi R Amiji M Stomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils Int J Pharm 2004 272 1–2 99 108 15019073 

  91. 91 Jing ZW Jia YY Wan N Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori Biomaterials 2016 84 276 285 26851392 

    상세보기

  92. 92 Luo M Jia YY Jing ZW Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori Colloids Surf B Biointerfaces 2018 164 11 19 29367052 

    상세보기

  93. 93 Khutoryanskiy VV Beyond PEGylation: alternative surface-modification of nanoparticles with mucus-inert biomaterials Adv Drug Deliv Rev 2018 124 140 149 28736302 

    상세보기

  94. 94 Hayden SC Zhao G Saha K Aggregation and interaction of cationic nanoparticles on bacterial surfaces J Am Chem Soc 2012 134 16 6920 6923 22489570 

    상세보기

  95. 95 Westmeier D Posselt G Hahlbrock A Nanoparticle binding attenuates the pathobiology of gastric cancer-associated Helicobacter pylori Nanoscale 2018 10 3 1453 1463 29303193 

    상세보기

  96. 96 Yu H Guo C Feng B Triple-layered pH-responsive micelleplexes loaded with siRNA and cisplatin prodrug for NF-Kappa B targeted treatment of metastatic breast cancer Theranostics 2016 6 1 14 27 26722370 

    상세보기

  97. 97 Rahme LG Stevens EJ Wolfort SF Shao J Tompkins RG Ausubel FM Common virulence factors for bacterial pathogenicity in plants and animals Science 1995 268 5219 1899 1902 7604262 

    상세보기

  98. 98 Su Y Zhao L Meng F Wang Q Yao Y Luo J Silver nanoparticles decorated lipase-sensitive polyurethane micelles for on-demand release of silver nanoparticles Colloids Surf B Biointerfaces 2017 152 238 244 28113126 

    상세보기

  99. 99 Chen YL Zhu S Zhang L Smart conjugated polymer nanocarrier for healthy weight loss by negative feedback regulation of lipase activity Nanoscale 2016 8 6 3368 3375 26790821 

    상세보기

  100. 100 Xu L He C Hui L Bactericidal dendritic polycation cloaked with stealth material via lipase-sensitive intersegment acquires neutral surface charge without losing membrane-disruptive activity ACS Appl Mater Interfaces 2015 7 50 27602 27607 26632646 

    상세보기

  101. 101 Yang S Han X Yang Y Bacteria-targeting nanoparticles with microenvironment-responsive antibiotic release to eliminate intracellular Staphylococcus aureus and associated infection ACS Appl Mater Interfaces 2018 10 17 14299 14311 29633833 

    상세보기

  102. 102 Rezaee R Talebreza A Ziari K Behnod V Emampour BFS Distribution of virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli isolated from diabetic and healthy males suffered from urinary tract infections Biosci Biotechnol Res Asia 2016 13 2 931 937 

    상세보기

  103. 103 Lim YM de Groof AJC Bhattacharjee MK Figurski DH Schon EA Bacterial conjugation in the cytoplasm of mouse cells Infect Immun 2008 76 11 5110 5119 18765719 

    상세보기

  104. 104 Marshall TG Lee RE Marshall FE Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b Theor Biol Med Model 2006 3 1 1 16403216 

  105. 105 Pires-Lapa M Carvalho-Sousa C Cecon E Fernandes P Markus R β-adrenoceptors trigger melatonin synthesis in phagocytes Int J Mol Sci 2018 19 8 E2182 30049944 

  106. 106 Proal AD Albert PJ Marshall TG Blaney GP Lindseth IA Immu-nostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis Immunol Res 2013 56 2–3 398 412 23576059 

  107. 107 Aksungur P Demirbilek M Denkbaş EB Vandervoort J Ludwig A Unlü N Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies J Control Release 2011 151 3 286 294 21241752 

    상세보기

  108. 108 Mohammadi G Nokhodchi A Barzegar-Jalali M Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system Colloids Surf B Biointerfaces 2011 88 1 39 44 21752610 

    상세보기

  109. 109 Giannavola C Bucolo C Maltese A Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability Pharm Res 2003 20 4 584 590 12739765 

    상세보기

  110. 110 Couvreur P Fattal E Alphandary H Puisieux F Andremont A Intracellular targeting of antibiotics by means of biodegradable nanoparticles J Control Release 1992 19 1–3 259 267 

  111. 111 Ranjan A Pothayee N Seleem M Drug delivery using novel nanoplexes against a Salmonella mouse infection model J Nanopart Res 2010 12 3 905 914 

    상세보기

  112. 112 Sosnik A Carcaboso AM Glisoni RJ Moretton MA Chiappetta DA New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery Adv Drug Deliv Rev 2010 62 4–5 547 559 19914315 

  113. 113 Rawal T Butani S Combating tuberculosis infection: a forbidding challenge Indian J Pharm Sci 2016 78 1 8 16 27168676 

    상세보기

  114. 114 Chew NY Chan HK Use of solid corrugated particles to enhance powder aerosol performance Pharm Res 2001 18 11 1570 1577 11758765 

    상세보기

  115. 115 Lawlor C Kelly C O’Leary S Cellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTb Tuberculosis (Edinb) 2011 91 1 93 97 21237714 

    상세보기

  116. 116 Pandey R Sharma A Zahoor A Sharma S Khuller GK Prasad B Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis J Antimicrob Chemother 2003 52 6 981 986 14613962 

  117. 117 Fang G Li W Shen X Differential Pd-nanocrystal facets demonstrate distinct antibacterial activity against Gram-positive and Gram-negative bacteria Nat Commun 2018 9 1 129 29317632 

    상세보기

  118. 118 Choi SK Myc A Silpe JE Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface ACS Nano 2013 7 1 214 228 23259666 

    상세보기

  119. 119 Yu M Wang H Fu F Dual-recognition Förster resonance energy transfer based platform for one-step sensitive detection of pathogenic bacteria using fluorescent vancomycin-gold nanoclusters and aptamer-gold nanoparticles Anal Chem 2017 89 7 4085 4090 28287715 

  120. 120 Silvero CMJ Rocca DM de La Villarmois EA Selective photo-induced antibacterial activity of amoxicillin-coated gold nanoparticles: from one-step synthesis to in vivo cytocompatibility ACS Omega 2018 3 1 1220 1230 30023798 

  121. 121 Zhu M Liu W Liu H Construction of Fe 3 O 4 /Vancomycin/PEG magnetic nanocarrier for highly efficient pathogen enrichment and gene sensing ACS Appl Mater Interfaces 2015 7 23 12873 12881 26005899 

  122. 122 Wang C Zhang K Zhou Z Vancomycin-modified Fe(3)O(4)@SiO(2)@Ag microflowers as effective antimicrobial agents Int J Nanomedicine 2017 12 3077 3094 28450783 

  123. 123 Capeletti LB Loiola LMD Picco AS da Silva Liberato M Cardoso MB 8 – Silica nanoparticle applications in the biomedical field Ciofani G Smart Nanoparticles for Biomedicine Elsevier 2018 115 129 

  124. 124 Kim Y Park EJ Na DH Recent progress in dendrimer-based nano-medicine development Arch Pharm Res 2018 41 6 571 582 29450862 

    상세보기

  125. 125 Wu S Duan N Qiu Y Li J Wang Z Colorimetric aptasensor for the detection of Salmonella enterica serovar typhimurium using ZnFe 2 O 4- reduced graphene oxide nanostructures as an effective peroxidase mimetics Int J Food Microbiol 2017 261 42 48 28910678 

  126. 126 Angsantikul P Thamphiwatana S Zhang Q Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection Adv Ther (Weinh) 2018 1 2 1800016 30320205 

  127. 127 Muppidi K Wang J Betageri G Pumerantz AS PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin Antimicrob Agents Chemother 2011 55 10 4537 4542 21788465 

    상세보기

  128. 128 Kalhapure RS Sonawane SJ Sikwal DR Solid lipid nanoparticles of clotrimazole silver complex: an efficient nano antibacterial against Staphylococcus aureus and MRSA Colloids Surf B Biointerfaces 2015 136 651 658 26492156 

    상세보기

  129. 129 Pei Y Mohamed MF Seleem MN Yeo Y Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages J Control Release 2017 267 133 143 28797580 

    상세보기

  130. 130 Puisney C Baeza-Squiban A Boland S Mechanisms of uptake and translocation of nanomaterials in the lung Adv Exp Med Biol 2018 1048 21 36 29453530 

  131. 131 Berçot B Poirel L Dortet L Nordmann P In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae J Antimicrob Chemother 2011 66 10 2295 2297 21807739 

    상세보기

  132. 132 Johnson TJ Siek KE Johnson SJ Nolan LK DNA sequence of a ColV plasmid and prevalence of selected plasmid-encoded virulence genes among avian Escherichia coli strains J Bacteriol 2006 188 2 745 758 16385064 

  133. 133 Sercombe L Veerati T Moheimani F Wu SY Sood AK Hua S Advances and challenges of liposome assisted drug delivery Front Pharmacol 2015 6 127 286 26648870 

  134. 134 Deol P Khuller GK Joshi K Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice Antimicrob Agents Chemother 1997 41 6 1211 1214 9174172 

    상세보기

  135. 135 Ruckmani K Sankar V Sivakumar M Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes J Biomed Nanotechnol 2010 6 1 43 51 20499831 

    상세보기

  136. 136 Huang CT Stewart PS Reduction of polysaccharide production in Pseudomonas aeruginosa biofilms by bismuth dimercaprol (BisBAL) treatment J Antimicrob Chemother 1999 44 5 601 605 10552975 

  137. 137 Mahdiun F Mansouri S Khazaeli P Mirzaei R The effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosa Microb Pathog 2017 107 129 135 28323149 

    상세보기

  138. 138 Chitambar CR Gallium and its competing roles with iron in biological systems Biochim Biophys Acta 2016 1863 8 2044 2053 27150508 

  139. 139 Hammer ND Skaar EP Molecular mechanisms of Staphylococcus aureus iron acquisition Annu Rev Microbiol 2011 65 1 129 147 21639791 

  140. 140 Oh SH Park HS Kim HS Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens Int J Antimicrob Agents 2017 50 700 706 28668680 

  141. 141 Goderska K Agudo Pena S Alarcon T Helicobacter pylori treatment: antibiotics or probiotics Appl Microbiol Biotechnol 2018 102 1 1 7 29075827 

    상세보기

  142. 142 Trifan A Girleanu I Cojocariu C Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication World J Gastroenterol 2013 19 42 7476 7479 24259981 

  143. 143 Miernyk KM Bulkow LR Gold BD Prevalence of Helicobacter pylori among Alaskans: factors associated with infection and comparison of urea breath test and anti- Helicobacter pylori IgG antibodies Helicobacter 2018 23 3 e12482 29537130 

    상세보기

  144. 144 Wang YK Kuo FC Liu CJ Diagnosis of Helicobacter pylori infection: current options and developments World J Gastroenterol 2015 21 40 11221 11235 26523098 

  145. 145 Ramteke S Ganesh N Bhattacharya S Jain NK Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori J Drug Target 2008 16 9 694 705 18982518 

    상세보기

  146. 146 Camargo MC García A Riquelme A The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America Am J Gastroenterol 2014 109 4 485 495 24589670 

    상세보기

  147. 147 Li XX Shi S Rong L Feng MQ Zhong L The impact of liposomal linolenic acid on gastrointestinal microbiota in mice Int J Nanomedicine 2018 13 1399 1409 29563795 

  148. 148 Mullane K Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance Ther Adv Chronic Dis 2014 5 2 69 84 24587892 

    상세보기

  149. 149 Xu K Liang ZC Ding X Nanomaterials in the prevention, diagnosis, and treatment of Mycobacterium tuberculosis infections Adv Healthc Mater 2018 7 1 1700509 

    상세보기

  150. 150 Ai X Hu M Wang Z Recent advances of membrane-cloaked nanoplatforms for biomedical applications Bioconjug Chem 2018 29 4 838 851 29509403 

    상세보기

  151. 151 Hu CM Fang RH Luk BT Zhang L Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies Nanoscale 2014 6 1 65 75 24280870 

    상세보기

  152. 152 Escajadillo T Olson J Luk BT Zhang L Nizet V A red blood cell membrane-camouflaged nanoparticle counteracts streptolysin O -mediated virulence phenotypes of invasive Group A Streptococcus Front Pharmacol 2017 8 477 28769806 

  153. 153 Charoenphol P Oswalt K Bishop CJ Therapeutics incorporating blood constituents Acta Biomater 2018 73 64 80 29626699 

    상세보기

  154. 154 Zhang Y Zhang J Chen W Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection J Control Release 2017 263 185 191 28087406 

    상세보기

  155. 155 Chen Y Chen M Zhang Y Broad-spectrum neutralization of pore-forming toxins with human erythrocyte membrane-coated nanosponges Adv Healthc Mater 2018 7 13 e1701366 29436150 

  156. 156 Wei X Gao J Wang F In situ capture of bacterial toxins for antivirulence vaccination Adv Mater 2017 29 33 1701644 

  157. 157 Fang RH Luk BT Hu CM Zhang L Engineered nanoparticles mimicking cell membranes for toxin neutralization Adv Drug Deliv Rev 2015 90 69 80 25868452 

    상세보기

  158. 158 Jiang Y Fang RH Zhang L Biomimetic nanosponges for treating antibody-mediated autoimmune diseases Bioconjug Chem 2018 29 4 870 877 29357234 

    상세보기

  159. 159 Yuk SA Sanchez-Rodriguez DA Tsifansky MD Yeo Y Recent advances in nanomedicine for sepsis treatment Ther Deliv 2018 9 6 435 450 29722636 

    상세보기

  160. 160 Das S Angsantikul P Le C Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera PLoS Negl Trop Dis 2018 12 2 e0006266 29470490 

    상세보기

  161. 161 Gao W Fang RH Thamphiwatana S Modulating antibacterial immunity via bacterial membrane-coated nanoparticles Nano Lett 2015 15 2 1403 1409 25615236 

    상세보기

  162. 162 Shen H Ackerman AL Cody V Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles Immunology 2006 117 1 78 88 16423043 

    상세보기

  163. 163 Song C Noh YW Lim YT Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response Int J Nanomedicine 2016 11 3753 3764 27540289 

  164. 164 Bafica A Scanga CA Feng CG Leifer C Cheever A Sher A TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis J Exp Med 2005 202 12 1715 1724 16365150 

    상세보기

  165. 165 Weiss DS Raupach B Takeda K Akira S Zychlinsky A Toll-like receptors are temporally involved in host defense J Immunol 2004 172 7 4463 4469 15034062 

    상세보기

  166. 166 Lu D Garcia-Contreras L Xu D Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B Pharm Res 2007 24 10 1834 1843 17657598 

    상세보기

  167. 167 Cai H Hu XD Yu DH Li SX Tian X Zhu YX Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice Vaccine 2005 23 32 4167 4174 15908060 

    상세보기

  168. 168 Priyadarsini S Mukherjee S Mishra M Nanoparticles used in dentistry: a review J Oral Biol Craniofac Res 2018 8 1 58 67 29556466 

  169. 169 Kadiyala U Turali-Emre ES Bahng JH Kotov NA VanEpps JS Unexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant Staphylococcus aureus (MRSA) Nanoscale 2018 10 10 4927 4939 29480295 

    상세보기

  170. 170 De Matteis V Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro/in vivo toxicity evaluation Toxics 2017 5 4 E29 29051461 

  171. 171 Breznan D das DD O’Brien JS Differential cytotoxic and inflammatory potency of amorphous silicon dioxide nanoparticles of similar size in multiple cell lines Nanotoxicology 2017 11 2 223 235 28142331 

    상세보기

  172. 172 Jain AK Senapati VA Singh D Dubey K Maurya R Pandey AK Impact of anatase titanium dioxide nanoparticles on mutagenic and genotoxic response in Chinese hamster lung fibroblast cells (V-79): the role of cellular uptake Food Chem Toxicol 2017 105 127 139 28400324 

    상세보기

  173. 173 Vimbela GV Ngo SM Fraze C Yang L Stout DA Antibacterial properties and toxicity from metallic nanomaterials Int J Nanomedicine 2017 12 3941 3965 28579779 

  174. 174 Panáček A Smékalová M Kilianová M Strong and nonspecific synergistic antibacterial efficiency of antibiotics combined with silver nanoparticles at very low concentrations showing no cytotoxic effect Molecules 2015 21 1 E26 26729075 

  175. 175 Thorsing M Bentin T Givskov M Tolker-Nielsen T Goltermann L The bactericidal activity of β-lactam antibiotics is increased by metabolizable sugar species Microbiology 2015 161 10 1999 2007 26243263 

  176. 176 Rahman T Yarnall B Doyle DA Efflux drug transporters at the forefront of antimicrobial resistance Eur Biophys J 2017 46 7 647 653 28710521 

  177. 177 Stokes JM MacNair CR Ilyas B Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance Nat Microbiol 2017 2 5 17028 28263303 

  178. 178 Melander RJ Melander C The challenge of overcoming antibiotic resistance: an adjuvant approach? ACS Infect Dis 2017 3 8 559 563 28548487 

    상세보기

  179. 179 Wu SY Park GY Kim SH Hulme J An SSA Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7 Drug Des Devel Ther 2016 10 3363 3378 

  180. 180 Milton ME Minrovic BM Harris DL Re-sensitizing multi-drug resistant bacteria to antibiotics by targeting bacterial response regulators: characterization and comparison of interactions between 2-aminoimidazoles and the response regulators BfmR from Acinetobacter baumannii and QseB from Francisella spp Front Mol Biosci 2018 5 15 29487854 

  181. 181 Jamil B Habib H Abbasi SA Ihsan A Nasir H Imran M Development of cefotaxime impregnated chitosan as nano-antibiotics: de novo strategy to combat biofilm forming multi-drug resistant pathogens Front Microbiol 2016 7 330 27047457 

    상세보기

  182. 182 Meng J He G Wang H Reversion of antibiotic resistance by inhibiting mecA in clinical methicillin-resistant Staphylococci by antisense phosphorothioate oligonucleotide J Antibiot 2015 68 3 158 164 25269464 

    상세보기

  183. 183 Bikard D Euler CW Jiang W Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials Nat Biotechnol 2014 32 11 1146 1150 25282355 

  184. 184 Luo ML Leenay RT Beisel CL Current and future prospects for CRISPR-based tools in bacteria Biotechnol Bioeng 2016 113 5 930 943 26460902 

    상세보기

  185. 185 Giau VV Lee H Shim KH Bagyinszky E An SSA Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer’s disease Clin Interv Aging 2018 13 221 233 29445268 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로